[Parameters of cellular immunity in lung cancer patients with different types of adaptation reactions during polychemotherapy].
A relationship between cellular immunity and general adaptation syndrome in the course of CAM polychemotherapy has been investigated. The results point to a lack of lymphopenia, lower levels of T-suppressors and higher instability of immunological indices in patients showing increased activation reaction and maximum antitumor resistance during cytostatic therapy, unlike in those in stress. This opens an opportunity for correction.
Stakheeva
M N
MN
Research Institute of Pharmacology, Russian Academy of Medical Sciences, Tomsk.
Dizer
I A
IA
Smol'ianinov
E S
ES
Goldberg
V E
VE
Novitskiĭ
E V
EV
Sherstoboev
E Iu
EIu
Khlusova
M Iu
MIu
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000276:immunology* / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000276:immunology; D004317:Doxorubicin / Q000276:immunology; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000276:immunology*; D008214:Lymphocytes / Q000187:drug effects*; D008297:Male; D008727:Methotrexate / Q000276:immunology; D008875:Middle Aged; D013601:T-Lymphocytes / Q000187:drug effects
D004317:Doxorubicin; D003520:Cyclophosphamide; D008727:Methotrexate
Pokazateli kletochnogo immuniteta u bol'nykh rakom lëgkogo s razlichnymi tipami adaptatsionnykh reaktsiĭ v protzesse provedeniia polikhimioterapii.